{"nct_id":"NCT06564324","title":"A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients","status":"RECRUITING","status_verified_date":"2024-08","start_date":"2024-11-27","start_date_type":"ACTUAL","primary_completion_date":"2029-01","primary_completion_date_type":"ESTIMATED","completion_date":"2030-09","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NUVB"]}